Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.33 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.33 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9324958 | 1.00 | SMN1; SMN2 (0.33) | SMN1; SMN2HIF1AGLRA1SLC6A9OR51E2 | |
| SCHEMBL15757119 | 0.84 | KIF11 (0.33) | — | |
| SCHEMBL349825 | 0.78 | GLRA1 (0.38) | SMN1; SMN2HIF1AGLRA1SLC6A9OR51E2 | |
| SCHEMBL8819893 | 0.77 | FFAR3 (0.36) | SMN1; SMN2HIF1A | |
| SCHEMBL8820876 | 0.75 | GRM2 (0.34) | — | |
| SCHEMBL4361740 | 0.74 | MEN1 (0.39) | SMN1; SMN2HIF1AGLRA1SLC6A9OR51E2 | |
| SCHEMBL121974 | 0.74 | SMN1; SMN2 (0.34) | SMN1; SMN2HIF1A | |
| SCHEMBL3921490 | 0.74 | SMN1; SMN2 (0.34) | SMN1; SMN2HIF1A | |
| SCHEMBL4223500 | 0.71 | GSR (0.47) | — | |
| SCHEMBL6937476 | 0.71 | FAAH (0.47) | OR51E2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1184038-B1 | SYSTEM FOR RELEASE IN LOWER DIGESTIVE TRACT | MOCHIDA PHARM CO LTD (JP) | 2005-12-28 | — | — | EP | claimed |
| EP-1144613-B2 | METHODS FOR MAKING PROTEINS CONTAINING FREE CYSTEINE RESIDUES | BOLDER BIOTECHNOLOGY INC (US) | 2020-05-06 | — | — | EP | disclosed |
| US-20170362626-A1 | METHODS FOR MAKING PROTEINS CONTAINING FREE CYSTEINE RESIDUES | BOLDER BIOTECHNOLOGY, INC. | 2017-12-21 | — | — | US | disclosed |
| US-20160244798-A1 | METHODS FOR MAKING PROTEINS CONTAINING FREE CYSTEINE RESIDUES | BOLDER BIOTECHNOLOGY, INC. | 2016-08-25 | — | — | US | disclosed |
| EP-2305804-B1 | MonoPEGylated human growth hormone | BOLDER BIOTECHNOLOGY INC (US) | 2015-05-06 | — | — | EP | disclosed |
| EP-1799188-B1 | USE OF PEPTIDES AS AN ANTIOXIDANT AGENT FOR THE PREPARATION OF A COSMETIC AND/OR PHARMACEUTICAL COMPOSITION | ASHLAND SPECIALTIES FRANCE (FR) | 2015-05-06 | — | — | EP | disclosed |
| US-8957023-B2 | Methods for making proteins containing free cysteine residues | BOLDER BIOTECHNOLOGY INC. (US) | 2015-02-17 | — | — | US | disclosed |
| US-8932828-B2 | Method for preparing recombinant granulocyte colony stimulating factor cysteine muteins | BOLDER BIOTECHNOLOGY, INC. (US) | 2015-01-13 | — | — | US | disclosed |
| US-8580159-B2 | Ink for inkjet recording, ink set for inkjet recording, ink media set for inkjet recording, ink cartridge, inkjet recording method, and inkjet recording apparatus | RICOH COMPANY, LTD. (JP) | 2013-11-12 | — | — | US | disclosed |
| US-20130217629-A1 | METHODS FOR MAKING PROTEINS CONTAINING FREE CYSTEINE RESIDUES | BOLDER BIOTECHNOLOGY, INC. (US) | 2013-08-22 | — | — | US | disclosed |
| WO-2001087925-A2 | METHODS FOR REFOLDING PROTEINS CONTAINING FREE CYSTEINE RESIDUES | BOLDER BIOTECHNOLOGY, INC. (US) | 2001-11-22 | — | — | WO | disclosed |
| EP-1144613-A1 | METHODS FOR MAKING PROTEINS CONTAINING FREE CYSTEINE RESIDUES | Bolder Biotechnology, Inc. (US) | 2001-10-17 | — | — | EP | disclosed |
| WO-2000042175-A1 | METHODS FOR MAKING PROTEINS CONTAINING FREE CYSTEINE RESIDUES | BOLDER BIOTECHNOLOGY INC. (US) | 2000-07-20 | — | — | WO | disclosed |
| EP-1001685-A1 | NUTRITIONAL COMPOSITION CONTAINING METHIONINE | N.V. Nutricia (NL) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999003365-A1 | NUTRITIONAL COMPOSITION CONTAINING METHIONINE | N.V. NUTRICIA (NL) | 1999-01-28 | — | — | WO | disclosed |
| EP-0891719-A1 | Nutritional composition containing methionine | N.V. Nutricia (NL) | 1999-01-20 | — | — | EP | disclosed |
| EP-0264953-B1 | USE OF N,N'-BIS-L-AMINO ACID-L-CYSTIN PEPTIDES IN AMINO ACID PREPARATIONS FOR ORAL AND PARENTERAL ADMINISTRATION | PFRIMMER KABI GMBH & CO. KG (DE) | 1991-05-08 | — | — | EP | disclosed |
| US-4968696-A | CHRONIC UREMIA OR HEPATIC CIRRHOSIS | PFRIMMER + CO. PHARMAZEUTISCHE WERKE ERLANGEN GMBH + CO. KG (DE) | 1990-11-06 | — | — | US | disclosed |
| WO-1988003150-A2 | N,N'-BIS-AMINO ACID-L-CYSTINE-PEPTIDE-CONTAINING AMINO ACID PREPARATIONS FOR ORAL AND PARENTERAL ADMINISTRATION | PFRIMMER + CO. PHARMAZEUTISCHE WERKE ERLANGEN GMBH (DE) | 1988-05-05 | — | — | WO | disclosed |
| EP-0264953-A2 | Use of N,N'-bis-L-amino acid-L-cystin peptides in amino acid preparations for oral and parenteral administration | PFRIMMER KABI GMBH & CO. KG (DE) | 1988-04-27 | — | — | EP | disclosed |